Company Overview and News

0
Godrej Properties Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-08-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GODREJPROP 533150

0
Godrej Properties Limited - Shareholders meeting

2018-08-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GODREJPROP 533150

0
Godrej Properties’ net profit falls 65% in Q1

2018-08-02 livemint
Mumbai: Godrej Properties Ltd (GPL) on Thursday said its June quarter net profit fell 65.41% from a year ago to ₹34.30 crore on higher expenses, fewer new bookings and a change in accounting standards.
GODREJPROP 533150

0
Godrej Properties stock falls 4% after dismal earnings performance in Q1FY19

2018-08-02 moneycontrol
Share price of Mumbai-based real estate developer Godrej Properties fell more than 4 percent intraday Thursday after starting off the financial year 2018-19 on a weak note.
GODREJPROP 533150

1
ONGC, GIC Housing, MOIL, Pfizer results

2018-08-01 thehindubusinessline
Seventy three companies including Akzo Nobel India, Avantel, Capital First, Deepak Nitrite, GE Power, GIC Housing Finance, Godrej Properties, Ibulls Housing Fin, International Paper, JK Lakshmi Cement, Mahindra Logistics, Mahindra Holidays, Manpasand, Majesco, Marico, MOIL, ONGC, Pfizer, Ramco Cements, Rane Holdings, Raunaq EPC, Transport Corporation, Torrent Pharma and Uttam Sugar will declare their quarterly results for the April-June period on Thursday
GICHSGFIN BAJAJ-AUTO 500710 532938 533150 RMCTY INPAP CAPF 532977 511676 DEEPAKNI 500380 500260 GODREJPROP IP RANEHOLDIN RAMCOCEM AKZOINDIA JKLAKSHMI 505800 506401

0
Godrej Properties Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-07-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GODREJPROP 533150

0
Godrej Agrovet chairman Nadir Godrej: We are doing lot of R&D in Agri-chemicals

2018-07-19 freepressjournal.in
The beautiful view of mangroves from one of the top floors of Godrej One, Vikhroli, Mumbai is the backdrop of a candid interview with Godrej Agrovet chairman Nadir Godrej. He has a great deal to share – when it comes to the vision he has for his company. He also talks about the amazing R&D the company is doing. One such appealing R&D of the company is taking algae from its backyard mangroves to develop an entirely new range of products.
GODREJPROP AVANTI 533150 512573

0
Godrej Agrovet chairman Nadir Godrej: We are doing lot of R&D in Agri-chemicals

2018-07-18 freepressjournal.in
The beautiful view of mangroves from one of the top floors of Godrej One, Vikhroli, Mumbai is the backdrop of a candid interview with Godrej Agrovet chairman Nadir Godrej. He has a great deal to share – when it comes to the vision he has for his company. He also talks about the amazing R&D the company is doing. One such appealing R&D of the company is taking algae from its backyard mangroves to develop an entirely new range of products.
GODREJPROP AVANTI 533150 512573

0
IFC sells shares of AU Small Finance Bank worth Rs 201 crore

2018-07-13 moneycontrol
World Bank arm International Finance Corporation (IFC) today sold 32 lakh shares of AU Small Finance Bank for Rs 201.6 crores through an open market transaction. However, the buyer of the shares could not be ascertained immediately.
GODREJPROP IFK IFX 533150

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...